{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:06:57Z","timestamp":1784794017186,"version":"3.55.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Conventional influenza vaccine can prevent infection and reduce the risk of post-infection complications. However, they lack the capacity to effectively respond to influenza virus mutations. This results in the vaccine becoming ineffective due to a reduced antigenic match. It is necessary to develop a new strategy for vaccine that will provide broad cross-reactive protection. A DNA vaccine based on the hemagglutinin (HA) gene and conserved antigenic epitopes of both the HA, M2e and NA genes to provide protection against influenza B was developed. BALB\/c mice were immunized with electroporation to evaluate both humoral immune responses and T cell responses. Protection against influenza B virus challenge was evaluated in DNA vaccinated mice, followed by analysis of lung tissue to assess changes in cytokine levels and virus load. Additionally, various assays with DNA were conducted to assess their cellular uptake by DCs and their potential for immune activation. Vaccine\n                    <jats:italic>via<\/jats:italic>\n                    electroporation demonstrated the ability to enhance both humoral and cellular immune responses and resulted in the shaping of the immune response to the vaccine in a Th1 direction. Animals inoculated with vaccines\n                    <jats:italic>via<\/jats:italic>\n                    electroporation were completely protected against both homologous and heterologous viruses, as evidenced by the reduction of lung viral loads and lung inflammation, induction of broadly cross-protective humoral immunity, and IL-2 CD4\n                    <jats:sup>+<\/jats:sup>\n                    T-cell responses. The most significant finding was that the DNA vaccine provided complete protection for mice against two distinct lineages of the lethal influenza B virus. These findings suggested that DNA vaccine delivered using\n                    <jats:italic>in vivo<\/jats:italic>\n                    electroporation effectively elicits a protective immune response and provides additional cross-protection.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1645744","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:31:11Z","timestamp":1761715871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A DNA vaccine based on hemagglutinin and conserved epitopes of influenza B virus provides cross-lineage protection in mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiangyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1003550","DOI":"10.1371\/journal.pmed.1003550","article-title":"Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis","volume":"18","author":"Lafond","year":"2021","journal-title":"PloS Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu269","article-title":"Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection","volume":"59","author":"Su","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-u","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41467-022-29402-5","article-title":"Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination","volume":"13","author":"Dhanasekaran","year":"2022","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2200753","DOI":"10.2807\/1560-7917.ES.2022.27.39.2200753","article-title":"Has influenza B\/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines","volume":"27","author":"Paget","year":"2022","journal-title":"Euro Surveill"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02628-13","article-title":"Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y","volume":"58","author":"Burnham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710302200","article-title":"Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus","volume":"283","author":"Ma","year":"2008","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6706a1","article-title":"Update: influenza activity - United States, october 1, 2017-February 3, 2018","volume":"67","author":"Budd","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B10","unstructured":"Effectiveness of seasonal flu vaccines from the 2009\u20132024 flu seasons 2024\n          \n          2024"},{"key":"B11","unstructured":"ranscript for CDC update on flu activity 2023\n          \n          2024"},{"key":"B12","article-title":"Influenza update N\u00b0","year":"2024"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.14","article-title":"M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection","volume":"11","author":"Eliasson","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.06.015","article-title":"A perspective on the structural and functional constraints for immune evasion: insights from influenza virus","volume":"429","author":"Wu","year":"2017","journal-title":"J Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00076","article-title":"Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design","volume":"2","author":"Kaminski","year":"2011","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1541408","article-title":"Universal influenza vaccines: from viruses to nanoparticles","volume":"17","author":"Wang","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00560-19","DOI":"10.1128\/mBio.00560-19","article-title":"Mucosal immunity against neuraminidase prevents influenza B virus transmission in Guinea pigs","volume":"10","author":"McMahon","year":"2019","journal-title":"mBio"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e01673-18","DOI":"10.1128\/JVI.01673-18","article-title":"Antibody responses toward the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets, and humans","volume":"3","author":"Sun","year":"2019","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"mBio"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.84","article-title":"DNA vaccine manufacture: scale and quality","volume":"8","author":"Cai","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.advms.2023.05.003","article-title":"The development of DNA vaccines against SARS-CoV-2","volume":"68","author":"Khalid","year":"2023","journal-title":"Adv Med Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e009010","DOI":"10.1136\/bmjgh-2022-009010","article-title":"COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps","volume":"7","author":"Lazarus","year":"2022","journal-title":"BMJ Glob Health"},{"key":"B27","unstructured":"Manual for the laboratory diagnosis and virological surveillance of influenza 2011\n          \n          2024"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01732-8","article-title":"Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin","volume":"9","author":"Edler","year":"2024","journal-title":"Nat Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-020-0626-6","article-title":"Better influenza vaccines: an industry perspective","volume":"27","author":"Chen","year":"2020","journal-title":"J BioMed Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090350","article-title":"Are we ready for pandemic influenza","volume":"302","author":"Webby","year":"2003","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.023","article-title":"Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis","volume":"36","author":"Morimoto","year":"2018","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02005","article-title":"Vaccination with viral vectors expressing chimeric hemagglutinin, NP and M1 antigens protects ferrets against influenza virus challenge","volume":"10","author":"McMahon","year":"2019","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/vaccines7030117","article-title":"An inactivated influenza virus vaccine approach to targeting the conserved hemagglutinin stalk and M2e domains","volume":"7","author":"Sun","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.095","article-title":"Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice","volume":"37","author":"Asthagiri","year":"2019","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/srep24402","article-title":"Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies","volume":"6","author":"Schotsaert","year":"2016","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.6.6201","article-title":"Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines","volume":"4","author":"Johansson","year":"2008","journal-title":"Hum Vaccin"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.12.7380-7388.2005","article-title":"Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor","volume":"79","author":"Bianchi","year":"2005","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coi.2018.04.002","article-title":"Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus","volume":"53","author":"Tan","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e00286-17","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model","volume":"91","author":"Ermler","year":"2017","journal-title":"J Virol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03060-15","article-title":"Influenza A viruses expressing intra- or intergroup chimeric hemagglutinins","volume":"90","author":"Chen","year":"2016","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.12-1493","article-title":"Construction and characterization of retroviral vectors expressing biologically active human interleukin-12","volume":"5","author":"Zitvogel","year":"1994","journal-title":"Hum Gene Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0243","article-title":"Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice","volume":"3","author":"Scappaticci","year":"2001","journal-title":"Mol Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2005.07.689","article-title":"et al: Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma","volume":"12","author":"Ohlfest","year":"2005","journal-title":"Mol Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.050","article-title":"Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation","volume":"56","author":"Kupatt","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5493\/wjem.v5.i1.11","article-title":"Internal ribosome entry site-based vectors for combined gene therapy","volume":"5","author":"Renaud-Gabardos","year":"2015","journal-title":"World J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105978","article-title":"Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses","volume":"230","author":"Han","year":"2024","journal-title":"Antiviral Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.06.007","article-title":"Coronavirus vaccine-associated lung immunopathology-what is the significance","volume":"22","author":"Bottazzi","year":"2020","journal-title":"Microbes Infect"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"DiPiazza","year":"2021","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2427792","article-title":"Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains","volume":"13","author":"Zhang","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"B59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41467-018-08165-y","article-title":"Cross-lineage protection by human antibodies binding the influenza B hemagglutinin","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050396","article-title":"The IgG Fc receptor family","volume":"76","author":"Gessner","year":"1998","journal-title":"Ann Hematol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.161.1.1","article-title":"Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies","volume":"161","author":"Kipps","year":"1985","journal-title":"J Exp Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90115-5","article-title":"FcR gamma chain deletion results in pleiotrophic effector cell defects","volume":"76","author":"Takai","year":"1994","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cancers15010238","article-title":"HIV-1 protease as DNA immunogen against drug resistance in HIV-1 infection: DNA immunization with drug resistant HIV-1 protease protects mice from challenge with protease-expressing cells","volume":"15","author":"Petkov","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B64","doi-asserted-by":"publisher","first-page":":2259","DOI":"10.3390\/pharmaceutics14112259","article-title":"Optimization of in vivo electroporation conditions and delivery of DNA vaccine encoding SARS-CoV-2 RBD using the determined protocol","volume":"14","author":"Kisakov","year":"2022","journal-title":"Pharmaceutics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e0009374","DOI":"10.1371\/journal.pntd.0009374","article-title":"DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss","volume":"15","author":"Chai","year":"2021","journal-title":"PloS Negl Trop Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0007042","DOI":"10.1371\/journal.pntd.0007042","article-title":"Protective immunity by an engineered DNA vaccine for Mayaro virus","volume":"13","author":"Choi","year":"2019","journal-title":"PloS Negl Trop Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41541-022-00461-5","article-title":"Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters","volume":"7","author":"Babuadze","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0384-8","article-title":"Electroporation for therapeutic DNA vaccination in patients","volume":"204","author":"Sallberg","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110901","article-title":"Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses","volume":"39","author":"Hinke","year":"2022","journal-title":"Cell Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen presentation and T cell stimulation by dendritic cells","volume":"20","author":"Guermonprez","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2008.08.043","article-title":"Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes","volume":"382","author":"Speth","year":"2008","journal-title":"Virology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cellimm.2009.10.009","article-title":"Dendritic cell-derived TNF-alpha is responsible for development of IL-10-producing CD4+ T cells","volume":"261","author":"Hirata","year":"2010","journal-title":"Cell Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901358","article-title":"TNF-alpha regulates human plasmacytoid dendritic cells by suppressing IFN-alpha production and enhancing T cell activation","volume":"206","author":"Psarras","year":"2021","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1645744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:31:14Z","timestamp":1761715874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1645744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2025.1645744"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1645744","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1645744"}}